Trials tagged with: "acute myelogenous leukaemia (aml)"

book icon

AC220 in patients with AML

A phase 2 open label, AC220 monotherapy efficacy study in patients with acute myeloid leukaemia (AML) with FLT3-ITD activating mutations.